The nuclear medicine department of the Mont-de-Marsan hospital has been offering, since May 2026, a new targeted treatment for prostate cancer.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.